Jonathan Wong
Optometrist · Houston, TXNPI 1265473789
Payments from drug & device makers
Across 66 payments — averaging $76.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Optos, Inc.$816
- Glaukos Corporation$576
- Bausch & Lomb, A Division Of Bausch Health US, LLC$359
- Coopervision Inc.$323
- Dompe US, Inc.$238
- plus $2K from 14 others
What the payments were for
- Food & beverage$4,49588%
- Entertainment$58512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 18 | $1,215 |
| Optos, Inc. | 8 | $816 |
| Glaukos Corporation | 4 | $576 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 12 | $359 |
| Coopervision Inc. | 4 | $323 |
| Dompe US, Inc. | 2 | $238 |
| Sun Pharmaceutical Industries Inc. | 2 | $204 |
| ABB Con-cise Optical Group LLC | 3 | $183 |
| Apellis Pharmaceuticals, Inc. | 1 | $146 |
| Amgen | 1 | $143 |
| Carl Zeiss Meditec USA, Inc. | 1 | $123 |
| Astellas Pharma US Inc | 1 | $122 |
| AstraZeneca | 1 | $122 |
| Biotissue Holdings Inc. | 1 | $104 |
| Bausch & Lomb Americas Inc. | 2 | $102 |
| Harrow Eye, LLC | 1 | $99 |
| Aerie Pharmaceuticals, Inc. | 1 | $91 |
| LKC Technologies, Inc. | 1 | $76 |
| Shire North American Group Inc | 1 | $22 |
| AbbVie | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PANORAMIC OPHTHALMOSCOPE$1,177
- OCT OPHTHALMOSCOPE$1,033
- NFC-700$589
- Precision 1$568
- DAILIES$354
- Photrexa Viscous and Photrexa$352
- Oxervate$238
- TOTAL30$224
- TEPEZZA$143
- iDoseTR$125
- ULTOMIRIS$122
- Izervay$122
- AIR OPTIX$116
- BIOTRUE ONE DAY$116
- ALDEN SCLERAL ZENLENS$109
- DAILIES TOTAL1$107
- Precision7$107
- Systane$105
- Opti-Free$105
- Clear Care$105
How this compares
$5,080 in reported general payments places this provider in the 90th percentile of 4,315 optometrist providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyzultaLatanoprostene Bunod | 13 | $3,376 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Vyzulta | $102 | $3,37613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,315 optometrist providers in Texas.
Other optometrist in Houston
- Tiffany HuynhHouston$3.2M
- Bridgitte LeeHouston$3M
- Phillip BrunsonHouston$766K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$568K
- Kathryn RichdaleHouston$288K
- Nancy StephensHouston$241K
- Jelita Green-DathorneHouston$232K
- Eric RitcheyHouston$151K
- Maria WalkerHouston$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.